FDA Drug recall D-1403-2012
Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 5254…
- FDA Drug
- Class III
- terminated
- Published 2012-07-11
On 2012-07-11 the FDA classified a Class III recall of Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 5254… by Watson Laboratories, citing labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1403-2012 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2012-04-17 |
| Published | 2012-07-11 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Watson Laboratories |
| Distribution | US |
Product
Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 52544-495-01
Reason
Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
Identifiers
| code_info | Lot # 22478A |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1403-2012%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.